日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patient-physician discordance in goals of care for patients with advanced cancer

晚期癌症患者的治疗目标与医患意见不一致

Douglas, S L; Daly, B J; Meropol, N J; Lipson, A R

Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours.

循环细胞因子和单核细胞亚群作为舒尼替尼治疗晚期神经内分泌肿瘤患者的疗效和生物活性的生物标志物

Zurita A J, Khajavi M, Wu H-K, Tye L, Huang X, Kulke M H, Lenz H-J, Meropol N J, Carley W, DePrimo S E, Lin E, Wang X, Harmon C S, Heymach J V

Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers

参与肿瘤临床试验的态度障碍:因素分析及障碍的相关因素

Manne, S; Kashy, D; Albrecht, T; Wong, Y-N; Lederman Flamm, A; Benson, A B 3rd; Miller, S M; Fleisher, Linda; Buzaglo, J; Roach, N; Katz, M; Ross, E; Collins, M; Poole, D; Raivitch, S; Miller, D M; Kinzy, T G; Liu, T; Meropol, N J

Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer

一项针对晚期癌症患者的卡培他滨联合钇-90树脂微球(SIR-Spheres)放射性栓塞治疗的I期研究

Cohen, S J; Konski, A A; Putnam, S; Ball, D S; Meyer, J E; Yu, J Q; Astsaturov, I; Marlow, C; Dickens, A; Cade, D N; Meropol, N J

The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial

知识、自我效能、准备度、决策冲突以及参与癌症临床试验的决策之间的关系

Miller, S M; Hudson, S V; Egleston, B L; Manne, S; Buzaglo, J S; Devarajan, K; Fleisher, L; Millard, J; Solarino, N; Trinastic, J; Meropol, N J